Media Bites 28 March: GSK, Tyson Foods, Walmart

GlaxoSmithKline GSK

Glaxosmithkline (GSK) has agreed to take full control of its consumer healthcare joint venture from Novartis. It will buy the remaining 36.5% stake in the business, whose brands include Panadol and Sensodyne, for £9.2bn. It will also launch a strategic review of its nutrition products, including Horlicks to help fund ...

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now